Properties of CD8 T-cell-recognized neoantigens in different tumor types
Background: Neoantigen-based immunotherapies rely on computational tools predicting peptide immunogenicity based on properties such as its expression level, binding affinity to human leukocyte antigen (HLA), likelihood of proteasomal cleavage and dissimilarity from wild-type peptide. However, curren...
Saved in:
| Main Authors: | S.L.C. Ketelaars, M.M. van Buuren, A. Gangaev, N. van Rooij, S. Patiwael, K. Hoefakker, L.F. Fanchi, P. Baas, M. van der Heijden, M. Kok, T.N. Schumacher, P. Kvistborg, J.B.A.G. Haanen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Immuno-Oncology and Technology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S259001882500022X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HLA class II neoantigen presentation for CD4+ T cell surveillance in HLA class II-negative colorectal cancer
by: Satoru Matsumoto, et al.
Published: (2024-12-01) -
Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients
by: Sandra García-Mulero, et al.
Published: (2023-12-01) -
Shared neoantigens for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-06-01) -
Neoantigens: new hope for cancer therapy
by: Yitong Hu, et al.
Published: (2025-03-01) -
LRMAHpan: a novel tool for multi-allelic HLA presentation prediction using Resnet-based and LSTM-based neural networks
by: Xue Mi, et al.
Published: (2024-11-01)